Our Solutions

Technologies

InnoCore has two patented sustained release technologies which serve as a platform for obtaining advanced long-acting injectable (LAI) formulations of pharmaceutical ingredients.  The SynBiosys®  and InGell ® polymers are biodegradable and form a soft, localized drug depot upon injection. The long acting release mechanism of  drugs with SynBiosys® microspheres are based upon diffusion whereas the InGell® hydrogels use an eroding mechanism.

SynBiosys®

SynBiosys® is a sustained release technology for systemic and site-specific parenteral drug delivery. The technology uses...

Read more
InGell®

InGell® is an advanced injectable gel drug depot system, offering un-paralleled retention and release of active...

Read more

We use cookies for analyzing visitors behavior.